155 related articles for article (PubMed ID: 33978826)
1. Intratumoral Foxp3
Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
[TBL] [Abstract][Full Text] [Related]
2. Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Cao Y; He H; Li R; Liu X; Chen Y; Qi Y; Yu K; Wang J; Lin C; Liu H; Zhang H; Li H; Chen L; Zhang P; Shen Z; Huang H; Sun Y; Zhang W; Qin J; Xu J
Ann Surg; 2022 Jan; 275(1):e163-e173. PubMed ID: 32511132
[TBL] [Abstract][Full Text] [Related]
3. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J
Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848
[TBL] [Abstract][Full Text] [Related]
4. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J
Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266
[TBL] [Abstract][Full Text] [Related]
5. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating podoplanin
Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H
Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820
[TBL] [Abstract][Full Text] [Related]
8. Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Wang B; Li Y; Yang G
Int J Clin Exp Pathol; 2014; 7(8):4685-94. PubMed ID: 25197340
[TBL] [Abstract][Full Text] [Related]
9. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral CD103
Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758
[TBL] [Abstract][Full Text] [Related]
11. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W
Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216
[TBL] [Abstract][Full Text] [Related]
12. TIM3
Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R
Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
14. Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.
He X; Gu Y; Cao Y; Hu B; Fang H; Fei Y; Lv K; Liu X; Wang J; Lin C; Liu H; Zhang H; Li H; Li R; He H; Xu J
Eur J Cancer; 2021 Nov; 157():114-123. PubMed ID: 34508993
[TBL] [Abstract][Full Text] [Related]
15. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.
Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C
PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
17. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103
Li R; Liu H; Cao Y; Wang J; Chen Y; Qi Y; Lv K; Liu X; Yu K; Lin C; Zhang H; He H; Li H; Chen L; Shen Z; Qin J; Zhang W; Sun Y; Xu J
Br J Cancer; 2020 May; 122(10):1525-1534. PubMed ID: 32205862
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral CXCR5
Wang J; Li R; Cao Y; Gu Y; Fang H; Fei Y; Lv K; He X; Lin C; Liu H; Zhang H; Li H; He H; Xu J; Huang H
Nat Commun; 2021 May; 12(1):3080. PubMed ID: 34035252
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients.
Lv K; Li R; Cao Y; Gu Y; Liu X; He X; Jin K; Fang H; Fei Y; Shi M; Liu H; Li H; He H; Lin C; Zhang H; Xu J
Int J Cancer; 2021 Feb; 148(3):759-768. PubMed ID: 33105024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
